Bevacizumab vs Memantine

Bevacizumab vs Memantine: Overview

This comparison examines the pharmacological differences between Bevacizumab and Memantine.

Mechanism of Action

Memantine: Non-competitive NMDA receptor antagonist.

Pharmacokinetics

Half-life: Memantine — 60-80 hours.

Chemical Properties

Molecular Formula: Memantine — C12H21N.

Molecular Weight: Memantine — 179.3080 g/mol.

Type: Bevacizumab — Antibody; Memantine — Small molecule.